# Mechanism of PAVA-induced toxicity and inflammation in a cocultured skin cell model

**Authors:** Yunyang Song, Wenjie Cheng, Zhen Wang, Tianqi Zhou, Fanghui Wu, Yifeng Yin, Dan Xu, Yanli Liu

PMC · DOI: 10.3389/fphar.2025.1531459 · 2025-02-18

## TL;DR

This study shows that PAVA, a capsaicin-like compound, can harm skin cells by causing toxicity, oxidative stress, and inflammation in a lab model.

## Contribution

The study reveals the mechanisms of PAVA-induced toxicity and inflammation in a cocultured skin cell model.

## Key findings

- PAVA significantly inhibits cell proliferation in a dose- and time-dependent manner.
- PAVA induces apoptosis via both extrinsic and intrinsic pathways and increases ROS production.
- PAVA treatment leads to elevated secretion of pro-inflammatory cytokines IL-6 and IL-8.

## Abstract

Pelargonic acid vanillyl amide (PAVA), a stable synthetic analog of capsaicin, exhibits potential for therapeutic applications; however, it may present cytotoxic and pro-inflammatory risks. This study aims to investigate the injury effects of PAVA on a cocultured skin cell model in vitro.

Human keratinocytes and dermal fibroblasts were co-cultured and exposed to PAVA at concentrations ranging from 12.5 to 200 µM for durations of 5, 24, and 48 h. Cell proliferation was quantified using MTS assays. Morphological changes were observed through microscopy, reactive oxygen species (ROS) production was evaluated via fluorescence analysis, apoptosis was assessed using flow cytometry and Western blotting techniques, while inflammatory cytokines (IL-6, IL-8) were quantified by ELISA.

The proliferation of cells was significantly inhibited by PAVA in a dose- and time-dependent manner, with concentrations of 100 µM and above inducing substantiazl cytotoxicity. Morphological analysis revealed an increase in cell dispersion, irregular morphology, and apoptosis, particularly after prolonged exposure. Treatment with PAVA led to elevated levels of ROS, indicating the presence of oxidative stress. Apoptosis was initiated through both extrinsic pathways (NF-κB, Caspase-8) at an early stage and intrinsic pathways (Caspase-3/9, Bax) at a later period. Furthermore, PAVA markedly increased the secretion of IL-6 and IL-8, suggesting a robust pro-inflammatory response.

100 μM PAVA elicits pronounced cytotoxic, oxidative, and pro-inflammatory effects on cocultured skin cell model, particularly at higher concentrations and prolonged exposure durations. These findings underscore the necessity of exercising caution when employing PAVA for therapeutic purposes and highlight the imperative for further research to mitigate its adverse consequences as a riot control agent.

## Linked entities

- **Genes:** NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790], casp8 (caspase 8, apoptosis-related cysteine peptidase) [NCBI Gene 58022], Casp3 (caspase 3) [NCBI Gene 12367], Casp9 (caspase 9) [NCBI Gene 12371], BAX (BCL2 associated X, apoptosis regulator) [NCBI Gene 581]
- **Chemicals:** PAVA (PubChem CID 2998), IL-6 (PubChem CID 165368475), IL-8 (PubChem CID 169410440)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, CASP8 (caspase 8) [NCBI Gene 841] {aka ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5}, BAX (BCL2 associated X, apoptosis regulator) [NCBI Gene 581] {aka BCL2L4}
- **Diseases:** cytotoxic (MESH:D064420), inflammation (MESH:D007249)
- **Chemicals:** substantiazl cytotoxicity (-), capsaicin (MESH:D002211), ROS (MESH:D017382), PAVA (MESH:C098601)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11876130/full.md

---
Source: https://tomesphere.com/paper/PMC11876130